IKCS 2022: The New Era of Clinical Trials: Meeting Regulatory Requirements and Decreasing Barriers
Frontiers | Consensus Guidelines for Improving Quality of Assessment and Training for Neuromuscular Diseases
The Cost of Patient-Reported Outcomes in Medicine
Electronic Patient-Reported Outcomes: The Time Is Ripe for Integration Into Patient Care and Clinical Research | American Society of Clinical Oncology Educational Book
Patient-reported outcomes for diabetes and hypertension care in low- and middle-income countries: A scoping review | PLOS ONE
The value of patient-reported outcomes in early-phase clinical trials | Nature Medicine
Patient-reported outcomes: A new era in clinical research Deshpande PR, Rajan S, Sudeepthi B L, Abdul Nazir C P - Perspect Clin Res
The impact of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical analysis | Health and Quality of Life Outcomes | Full Text
Patient-Reported Outcomes (PROs) in HIV Infection: Points to Consider and Challenges | SpringerLink
Digital clinical trials: a new era - LaingBuisson News
Stepping up the decentralization of clinical trials | McKinsey
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM
The value of patient-reported outcomes in early-phase clinical trials | Nature Medicine
Patient-Reported Outcomes | Rethinking Clinical Trials®
Frontiers | Outcome Measures in Clinical Trials of Patients With Myasthenia Gravis
Artificial Intelligence for Clinical Trial Design: Trends in Pharmacological Sciences
Circulation: Heart Failure | AHA/ASA Journals
The impact of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical analysis | Health and Quality of Life Outcomes | Full Text
Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial - The Lancet Oncology
